Johnson & Johnson Receives Positive CHMP Opinion Recommending Full Approval For Sirturo For Treatment Of Multidrug-Resistant Tuberculosis

Johnson & Johnson +3.69%

Johnson & Johnson

JNJ

156.58

+3.69%

- Reuters

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via